| 234.57 -1.45 (-0.61%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 288.03 | 1-year : | 301.69 |
| Resists | First : | 246.6 | Second : | 258.29 |
| Pivot price | 238.28  |
|||
| Supports | First : | 227.67 | Second : | 189.42 |
| MAs | MA(5) : | 239.65 |
MA(20) : | 237.16 |
| MA(100) : | 220.35 |
MA(250) : | 206.56 |
|
| MACD | MACD : | 1.8 |
Signal : | 2.3 |
| %K %D | K(14,3) : | 42.4 |
D(3) : | 54.3 |
| RSI | RSI(14): 47.1 |
|||
| 52-week | High : | 258.29 | Low : | 144.36 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CAH ] has closed above bottom band by 32.4%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 240.99 - 243.31 | 243.31 - 244.7 |
| Low: | 227.69 - 230.71 | 230.71 - 232.54 |
| Close: | 231.11 - 236.02 | 236.02 - 238.99 |
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Fri, 11 Sep 2026
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue? - TradingView
Tue, 08 Sep 2026
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors - Yahoo Finance
Tue, 08 Sep 2026
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform? - Yahoo Finance
Mon, 07 Sep 2026
Cardinal Health, Inc. (CAH): Investor Outlook on a Healthcare Giant with a 9.61% Potential Upside - DirectorsTalk Interviews
Thu, 03 Sep 2026
Is Generics Still a Quiet Profit Engine for Cardinal Health? - Yahoo Finance
Mon, 24 Aug 2026
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 233 (M) |
| Shares Float | 232 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 91.1 (%) |
| Shares Short | 6,390 (K) |
| Shares Short P.Month | 6,750 (K) |
| EPS | 7.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -12.37 |
| Profit Margin | 0.6 % |
| Operating Margin | 1.3 % |
| Return on Assets (ttm) | 3.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 5.8 % |
| Gross Profit (p.s.) | 42 |
| Sales Per Share | 1093.17 |
| EBITDA (p.s.) | 18.23 |
| Qtrly Earnings Growth | 68.8 % |
| Operating Cash Flow | 5,170 (M) |
| Levered Free Cash Flow | 4,750 (M) |
| PE Ratio | 32.48 |
| PEG Ratio | 1.2 |
| Price to Book value | -18.97 |
| Price to Sales | 0.21 |
| Price to Cash Flow | 10.55 |
| Dividend | 0.51 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|